Palisade Bio
PALI
Palisade Bio (PALI) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Oct 13, 2026 |
| Raymond James | Initiated Coverage | Outperform | $6.00 | Oct 9, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Sep 23, 2026 |
| Oppenheimer | Initiated Coverage | Outperform | $8.00 | Jul 23, 2026 |
| Wolfe Research | Initiated Coverage | Outperform | $7.00 | Apr 9, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $7.00 | Mar 26, 2026 |
| Stifel | Initiated Coverage | Buy | $5.00 | Feb 25, 2026 |
| B. Riley Securities | Initiated Coverage | Buy | $7.00 | Jan 9, 2026 |
| Clear Street | Initiated Coverage | Buy | $12.00 | Dec 30, 2025 |
| Piper Sandler | Initiated Coverage | Overweight | $25.00 | Dec 29, 2025 |
| Brookline Capital | Maintained | Buy | $16.00 | May 13, 2025 |
| Brookline Capital | Initiated Coverage | Buy | $38.00 | Nov 20, 2024 |
| Maxim Group | Maintained | Buy | $8.00 from $22.50 | Nov 13, 2024 |
| Maxim Group | Maintained | Buy | $22.50 | May 1, 2024 |
| Maxim Group | Maintained | Buy | $22.50 | Apr 16, 2024 |
| Maxim Group | Upgraded | Hold → Buy | $1.50 | Nov 17, 2023 |
| Ladenburg Thalmann | Maintained | Buy | $16.00 from $25.00 | May 16, 2023 |
Frequently asked questions
What is the latest analyst rating on PALI?
On Oct 13, 2026, HC Wainwright & Co. maintained Palisade Bio at Buy with a price target of $7.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.